MUC-6 mucin is a major component of 'blood group substance' from human ovarian cyst fluid

Biochimica et Biophysica Acta - General Subjects

Volumn 1474, Issue 3, 2000, Pages 410-414

  Lloyd, Kenneth O ^a   Yin, Beatrice W T ^a   Tempst, Paul ^b   Erdjument Bromage, Hediye ^b  

^a Immunology Program   (United States)

^b Mem Sloan Kettering Cancer C   (United States)

Author keywords

Blood group antigen; MUC 6; Mucin; Ovarian cancer

Indexed keywords

BLOOD GROUP ANTIGEN; CARBOHYDRATE; EPITOPE; MUCIN; PEPTIDE;

ADENOMA; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; BLOOD GROUP; CYST FLUID; DEGLYCOSYLATION; FEMALE; HUMAN; OVARY CYST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; AMINO ACIDS; CHYMOTRYPSIN; CYST FLUID; FEMALE; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; MUCINS; OVARIAN CYSTS; TRYPSIN;

EID: 0034193804     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(00)00037-4     Document Type: Article

References (26)

1. W.M. Watkins, Biochemistry and genetics of the ABO, Lewis, and P blood group systems, in: Advances in Human Genetics, Plenum, New York, 1980, pp. 1-76.
2. K.O. Lloyd, Glycoproteins with blood group activity, in: International Review of Science. Organic Chemistry Series Two. Volume 7, Butterworths, London, 1976, pp. 252-281.
3. Lloyd K.O. Philip Levine award lecture. Blood group antigens as markers for normal differentiation and malignant change in human tissues. Am. J. Clin. Pathol. 87:1987;129-139.
4. Clausen H., Hakomori S.-I. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang. 56:1989;1-20.
5. E.A. Kabat, Blood Group Substances: Their Chemistry and Immunochemistry, Academic Press, New York, 1956.
6. Hakomori S. Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change. Semin. Hematol. 18:1981;39-62.
7. Gendler S.J., Spicer A.P. Epithelial mucin genes. Annu. Rev. Physiol. 57:1995;607-634.
8. Williams S.J., McGuckin M.A., Gotley D.C., Eyre H.J., Sutherland G.R., Antalis T.M. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res. 59:1999;4083-4089.
9. b substances. Proc. Natl. Acad. Sci. USA. 61:1968;1470-1477.
10. Gibbons R.A., Morgan W.T.J., Gibbons M. Studies in immunochemistry: 16. The isolation of blood-group active mucoids from ovarian cyst fluids. Biochem. J. 60:1955;428-436.
11. E.A. Kabat, Purification of Blood Group Substances, in: Blood Group Substances, Academic Press, New York, 1956, pp. 118-141.
12. Lloyd K.O., Savage A. High performance anion exchange (HPAE) chromatography of reduced oligosaccharides from sialomucins. Glycoconj. J. 8:1991;493-498.
13. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:1956;350-356.
14. Lui M., Tempst P., Erdjument-Bromage H. Methodical analysis of protein-nitrocellulose interactions to design a refined digestion protocol. Anal. Biochem. 241:1996;156-166.
15. Elicone C., Lui M., Geromanos S., Erdjument-Bromage H., Tempst P. Microbore reversed-phase high-performance liquid chromatographic purification of peptides for combined chemical sequencing/laser-desorption mass spectrometric analysis. J. Chromatogr. 676:1994;121-137.
16. Tempst P., Geromanos S., Elicone C., Erdjument-Bromage H. Improvements in microsequencer performance for low picomole sequence analysis. Methods Companion Methods Enzymol. 6:1994;248-261.
17. Erdjument-Bromage H., Lui M., Lacomis L., Grewal A., Annan R.S., McNulty D.E., Carr S.A., Tempst P. Examination of micro-tip reversed-phase liquid chromatographic extraction of peptide pools for mass spectrometric analysis. J. Chromatogr. 826:1998;167-181.
18. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
19. y) blood group antigen expression in epithelial ovarian cancer. Int. J. Cancer. 65:1996;406-412.
20. Mort A., Lamport D. Anhydrous hydrogen fluoride deglycosylates glycoproteins. Anal. Biochem. 82:1977;289-309.
21. Toribara N.W., Roberton A.M., Ho S.B., Kuo W.-L., Gum E., Hicks J.W., Gum J.R. Jr., Byrd J.C., Siddiki B., Kim Y.S. Human gastric mucin. Identification of a unique species by expression cloning. J. Biol. Chem. 268:1993;5879-5885.
22. Keates A.C., Nunes D.P., Afdhal N.H., Troxler R.F., Offner G.D. Molecular cloning of a major human gall bladder mucin: complete C-terminal sequence and genomic organization of MUC5B. Biochem. J. 324:1997;295-303.
23. Toribara N.W., Ho S.B., Gum J.R. Jr., Lau P., Kim Y.S. The carboxyl-terminal sequence of the human secretory mucin, MUC6 - analysis of the primary amino acid sequence. J. Biol. Chem. 272:1997;16398-16403.
24. Stern L., Palatsides M., deKretser T., Ford M. Expression of the tumor-associated mucin MUC1 in an ovarian tumor cell line. Int. J. Cancer. 50:1992;783-790.
25. Oosterkamp H.M., Scheiner L., Stefanova M.C., Lloyd K.O., Finstad C.L. Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z). Int. J. Cancer. 72:1997;87-94.
26. Donald A.S.R. The products of pronase digestion of purified blood group-specific glycoproteins. Biochim. Biophys. Acta. 317:1973;420-436.